SAIC-Frederick, Inc. and Fluidigm Corporation Collaborate to Decode Genome of Epstein-Barr Virus, a Cancer Risk-Factor

FREDERICK, Md. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--SAIC-Frederick, Inc. and Fluidigm Corporation are collaborating to decode the entire genome of the Epstein-Barr virus (EBV) using technology that can speed up research on the genetic basis of cancer and other diseases.

MORE ON THIS TOPIC